Brain natiuretic peptide and cardiac failure;Brain natriuretic peptide et insuffisance cardiaque

Archives des Maladies du Coeur et des Vaisseaux

Volumn 94, Issue 2, 2001, Pages 124-129

  Jourdain, P ^a   Funck, F ^a   Fulla, Y ^a   Bellorini, M ^a   Guillard, N ^a   Loiret, J ^a   Thebault, B ^a   Duboc, D ^a   Desnos, M ^a  

^a CENTRE HOSPITALIER RENÉ DUBOS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN NATRIURETIC PEPTIDE;

DIAGNOSTIC PROCEDURE; DISEASE SEVERITY; HEART FAILURE; HEART LEFT VENTRICLE FAILURE; HEART LEFT VENTRICLE MUSCLE; HUMAN; PROGNOSIS; PROTEIN BLOOD LEVEL; REVIEW; SCREENING TEST;

ANIMALS; BIOLOGICAL MARKERS; HEART FAILURE, CONGESTIVE; HEART VENTRICLES; HUMANS; MYOCARDIUM; NATRIURETIC PEPTIDE, BRAIN; VENTRICULAR DYSFUNCTION, LEFT;

EID: 0035118116     PISSN: 00039683     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (42)

1. The possible role of cardiac stretch receptors in the induction of changes in urine flow
2. Purification and complete amino acid sequence of alpha human atrial natriuretic peptide
3. Isolation and sequence determination of human brain natriuretic peptide in human atrium
4. Rat brain natriuretic peptide tissue distribution and molecular form
5. Expression of brain natriuretic peptide gene in human heart
6. Localization and mechanism of secretion of B type natriuretic peptide in comparison with those of A type natriuretic peptide in normal subjects and patients with heart failure
7. Brain natriuretic peptide as a novel Hormone in humans
8. Neonatal atria and ventricles secrete atrial natriuretic factor via tissue specific secretory pathways
9. Natriuretic peptide as cardiac hormones in normotensive and spontaneously hypertensive rats
10. Rapid ventricular induction of brain natrio-uretic peptide gene expression in experimental acute myocardial infarction
11. The protein kinase domain of the ANP receptor is required for signalling
12. Clearance function of type C receptors of atrial natriuretic peptide in rats
13. A 94 k-Da protein, identified as neutral endopeptidase 24.11, can inactivate atrial natriuretic peptide in the vascular endothelium
14. Brain Natriuretic Peptide: Possible role in the modulation of hypoxic pulmonary hypertension
15. Detection of left ventricular dysfunction after acute myocardial infarction: Comparison of clinical echocardiographic and neurohormonal methods
16. Comparison of secretion pattern between A type and B type Natriuretic peptides in patients with old myocardial infarction
17. Plasma brain natriuretic peptide is a biochemical marker for the prediction of progressive ventricular remodeling after acute myocardial infarction
18. Elevated B type natriuretic peptide levels after anthrocyclines administration
19. Natriuretic peptides and contractile reserve in dilated cardiomyopathy
20. Plasma brain natriuretic peptide in athletes
21. Expression of atrial and brain natriuretic peptides and their genes in hearts of patients with cardiac amylaidasis
22. Biochemical detection of left ventricular systalic dysfunction
23. Circulating N terminal atrial Natriuretic peptide as a marker for symptomless left ventricular dysfunction
24. Natriuretic peptide system in human heart failure
25. Attenuation of compensation of endogenous cardiac natriuretic peptide system in chronic heart failure
26. Plasma brain natriuretic peptide as a biochemical marker af high left ventricular end-diastolic pressure in patients with symptomatic left ventricular dysfunction
27. Plasma cardiac natriuretic peptide determination as a screening test for the detection of patients with mild left ventricular impairment
28. Comparison of atrial natriuretic peptide, B type natriuretic peptide and N terminal pro atrial natriuretic peptide as indicators of left ventricular systolic dysfunction
29. Different secretion patterns of atrial and brain natriuretic peptide in patients with congestive heart failure
30. Superiority of brain natriuretic peptide as a hormonal marker of left ventricular systolic and diastolic dysfunction and ventricular hypertrophy
31. Plasma brain natriuretic peptide in assesment of acute dsypnea
32. Value of natriuretic peptides in assesment of patients with possible new heart failure in primary care
33. Plasma N terminal prap brain natriuretic peptide and adrenomedullin
34. Neurahumoral prediction of benefit from Carvedilal in ischaemic left ventricular dysfunction
35. Effects of β blockade on neurohormonal responses to neurochemichal markers in pacing induced heart failure
36. Comparison of secretion pattern between A type and B type Natriuretic peptides in patients with old myocardial infarction
37. Plasma brain natriuretic peptide is a biochemical marker for the prediction of progressive ventricular remodeling after acute myocardial infarction
38. Elevated B type natriuretic peptide levels after anthrocyclines administration
39. Natriuretic peptides and contractile reserve in dilated cardiomyopathy
40. Effects of ACE inhibitors in the myocardial neuro-hormonal activation
41. Treatment of heart failure guided by plasma amino terminal natriuretic peptide concentrations